Table 2 Association between IMPC and clinicopathological characteristics
Clinicopathological characteristics | non-IMPC | IMPC | P | |
|---|---|---|---|---|
n (%) | n (%) | |||
Menopausal status | pre | 35 (50.0) | 13 (81.3) | 0.021 |
post | 35 (50.0) | 3 (18.8) | ||
Tumor size | 1 | 31 (44.9) | 2 (12.5) | 0.014 |
2–4 | 38 (55.1) | 14 (87.5) | ||
Lymph node status | 0 | 39 (55.7) | 5 (31.3) | 0.068 |
1–3 | 31 (44.3) | 11 (68.7) | ||
Clinical stage | I, II | 52 (74.3) | 13 (81.3) | 0.41 |
III | 18 (25.7) | 3 (18.7) | ||
Histological grade | 1,2 | 30 (46.2) | 5 (35.7) | 0.447 |
3 | 35 (53.8) | 9 (64.3) | ||
Estrogen receptor | Negative | 27 (38.6) | 2 (12.5) | 0.04 |
Positive | 43 (61.4) | 14 (87.5) | ||
Progesterone receptor | Negative | 33 (47.1) | 5 (31.3) | 0.248 |
Positive | 37 (52.9) | 11 (68.7) | ||